Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Med Chem ; 65(13): 9063-9075, 2022 07 14.
Artigo em Inglês | MEDLINE | ID: mdl-35785990

RESUMO

N-Methyl-d-aspartate receptor (NMDAR) positive allosteric modulators (PAMs) have received increased interest as a powerful mechanism of action to provide relief as therapies for CNS disorders. Sage Therapeutics has previously published the discovery of endogenous neuroactive steroid 24(S)-hydroxycholesterol as an NMDAR PAM. In this article, we detail the discovery of development candidate SAGE-718 (5), a potent and high intrinsic activity NMDAR PAM with an optimized pharmacokinetic profile for oral dosing. Compound 5 has completed phase 1 single ascending dose and multiple ascending dose clinical trials and is currently undergoing phase 2 clinical trials for treatment of cognitive impairment in Huntington's disease.


Assuntos
Doenças do Sistema Nervoso Central , Disfunção Cognitiva , Neuroesteroides , Regulação Alostérica , Disfunção Cognitiva/tratamento farmacológico , Humanos , Receptores de N-Metil-D-Aspartato/metabolismo
2.
J Med Chem ; 62(16): 7526-7542, 2019 08 22.
Artigo em Inglês | MEDLINE | ID: mdl-31390523

RESUMO

Neuroactive steroids (NASs) play a pivotal role in maintaining homeostasis is the CNS. We have discovered that one NAS in particular, 24(S)-hydroxycholesterol (24(S)-HC), is a positive allosteric modulator (PAM) of NMDA receptors. Using 24(S)-HC as a chemical starting point, we have identified other NASs that have good in vitro potency and efficacy. Herein, we describe the structure activity relationship and pharmacokinetic optimization of this series that ultimately led to SGE-301 (42). We demonstrate that SGE-301 enhances long-term potentiation (LTP) in rat hippocampal slices and, in a dose-dependent manner, improves cognition in a rat social recognition study.


Assuntos
Regulação Alostérica , Neuroesteroides/farmacologia , Receptores de N-Metil-D-Aspartato/metabolismo , Fatores Etários , Animais , Cognição/efeitos dos fármacos , Hipocampo/efeitos dos fármacos , Hipocampo/fisiologia , Humanos , Potenciação de Longa Duração/efeitos dos fármacos , Masculino , Metilação , Estrutura Molecular , Neuroesteroides/química , Neuroesteroides/farmacocinética , Ratos Wistar , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...